To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Star Trek Tricorder revisited: Toward a genre of medical scanners
06-01-2012: A hand-held scanner, reminiscent of the fictional Star Trek medical Tricorder, images blood vessels through the skin and projects a map onto the skin showing nurses exactly where to insert a needle. A pocket-sized device checks blood sugar levels through the skin of people with diabetes — no pinprick or blood sample needed. Those innovations are among a new genre of medical imaging technology that's giving doctors and scientists noninvasive views into the body to diagnose and study diseases. A report on the topic appears in Chemical & Engineering News.
In the article, Aaron Alexander Rowe focuses on new optical techniques that use laser beams or so-called near-infrared light to peer painlessly below the skin and through muscle and bone to see body structures. Near-infrared light, just beyond the range visible to the human eye, penetrates several inches into the human body. Two devices described in the article project a near-infrared beam into the skull. The light passes through brain tissue and blood vessels, and then scatters back out, where detectors analyze it in ways that promise to reveal whether patients are bleeding from a stroke or have other disorders.
The article explains that some of the new light-based medical diagnostic tools — the blood vessel mapper, for instance — already are in use in hospitals and clinics. Others are in various stages of pre-clinical development, including devices intended to spot skin cancer, monitor how breast cancer is responding to treatments and produce 3-D images of blockages in blood vessels.
- 1Panspecific antibodies: Novimmune successful in multiple specificities
- 2Rosetta Resolver® Gene Expression Data Analysis System licensed by Aventis Pharmaceuticals, Inc.
- 3Protein 'bar code' in spinal fluid could lead to first diagnostic test for Alzheimer's patients, Cornell researchers say
- 4Pharma’s New Hero: Supergenerics Save Money and Improve Drugs
- 5Pharmexa A/S sells Pharmexa-Epimmune to the Korean company VaxOnco, Inc.
- 67TM Pharma's new first-in-class anti-obesity drug completes Phase I/II clinical studies
- 7Takara Bio to Acquire Clontech Unit of BD Biosciences
- 8Merck KGaA Acquires Bioscience Company in India
- 9Bayer’s Novel Anticoagulant Xarelto now also Approved in the EU
- 10Sanofi-aventis to acquire Oenobiol
- Has a possible new lead been found in the fight against neurodegenerative di ...
- Precisely off the mark: Possible Cause Discovered For Failure of Targeted Li ...
- Fat and bone marrow-derived stem cells combo shows promise in preventing tra ...
- Immunotherapy set to revolutionise cancer treatment
- Cohesin: a cherry-shaped molecule safeguards cell-division
- Thermo Fisher Scientific and Samsung Electronics to Collaborate on Point-of-Care Diagnostic Solutions
- Fat and bone marrow-derived stem cells combo shows promise in preventing transplant rejection
- AMRI Announces Albuquerque, N.M. Manufacturing Facility Fully Operational
- The role DNA methylation plays in aging cells
- New insights from the Mouse ENCODE Project published in Genome Research